Skip to content

Viridian Therapeutics, Inc. VRDN Increase (Decrease) in Prepaid Expense and Other Assets

Increase (Decrease) in Prepaid Expense and Other Assets at other companies

Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$382K+92.4%
Vera Therapeutics logo
Vera TherapeuticsVERA
$5.14M-12.5%
PVL
Palvella TherapeuticsPVLA
$357K+144%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$6.38M+282%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
Arrowhead Research logo
Arrowhead ResearchARWR

Other financials

Income statement

See full
Revenue$141.0K+95.8%
Operating income-$116.2M-23.8%
Net income-$104.9M-20.7%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$176.3M+51.7%
Total debt$36.8M+59.4%
Total equity$636.0M+5.2%
Total assets$789.0M+19.4%

Cash flow

See full
Operating cash flow-$119.7M-29.1%
CapEx$23.0K-73.3%
Free cash flow-$119.7M-29.0%

Valuation

See full
Market cap$1.91B+82.0%
Enterprise value$1.77B+85.0%
P/S26.9×-3,445×

Profitability

See full
Gross margin36.3%
Operating margin-543.9%-271pp
Net margin-508.5%-254pp
FCF margin-428.4%-214pp

Returns & leverage

See full
Return on equity-58.1%+7.9pp
Debt / equity0.1×0.0×
Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets?
Viridian Therapeutics, Inc. (VRDN) reported increase (decrease) in prepaid expense and other assets of $2.33M in Q1 2026.
How has Viridian Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
Viridian Therapeutics, Inc.'s increase (decrease) in prepaid expense and other assets increased by 918.9% year-over-year, from -$285K to $2.33M.
What does increase (decrease) in prepaid expense and other assets mean?
This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.